AstraZeneca president 'would not back pricing deal again'

By Nick Renaud-Komiya2015-04-24T12:57:00

The UK president of drug giant AstraZeneca has indicated she would not sign up to another deal similar to the current pharmaceutical pricing scheme unless the NHS makes a ‘substantial’ increase of drugs access.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here